Clinical Trial Update: Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease [Phase 3]

View source ↗

Summary

Phase 3 safety and effectiveness study of the HERCULINK 14 Stent for renal artery obstruction was terminated, ending the trial early.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Artery Stenosis

Drugs mentioned

• HERCULINK 14 Stent

Snippet

Sponsor: Abbott Medical Devices | Conditions: Renal Artery Obstruction | Phase 3 | Status: TERMINATED